» Articles » PMID: 16219540

Efficient in Vitro Megakaryocyte Maturation Using Cytokine Cocktails Optimized by Statistical Experimental Design

Overview
Journal Exp Hematol
Specialty Hematology
Date 2005 Oct 13
PMID 16219540
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: A multi-step statistical strategy was applied to quantify individual and interactive effects of cytokines on megakaryopoiesis and to determine the concentration of the selected cytokines that optimize ex vivo megakaryocyte (MK) expansion, maturation, and platelet production in stromal- and serum-free conditions.

Materials And Methods: Immature MK were first generated from human CD34(+)-enriched cord blood cells cultured for 7 days in conditions favoring MK commitment. Then, the effect of different combinations of cytokines at various concentrations on MK differentiation and platelet production was tested on the day-7 MK.

Results: A large-scale screening of 13 cytokines in the presence of thrombopoietin (TPO) using Placket-Burman designs (PBD) was initially performed to identify stimulators of MK maturation. Afterwards, a statistical analysis of the two-level factorial designs revealed that in the presence of TPO, MK maturation was significantly stimulated by stem cell factor (SCF), interleukin (IL)-6, and IL-9, whereas Flt-3 ligand (FL) had a positive effect only on the expansion of MK progenitors. In contrast, erythropoietin (EPO) and IL-8 were inhibitors of MK maturation. A response surface methodology was then used to optimize the concentrations of the selected cytokines (TPO, SCF, IL-6, and IL-9) and defined a new cytokine cocktail that maximized MK expansion and maturation. Importantly, the increased MK output was accompanied by a very high MK purity ( approximately 90%). Another optimum was also found at a higher SCF concentration, which further improved MK expansion and maturation, but reduced MK purity.

Conclusion: These statistical methods provide an efficient tool to analyze complex systems of cytokines and to develop promising ex vivo MK culture systems for clinical applications.

Citing Articles

Lung megakaryocytes engulf inhaled airborne particles to promote intrapulmonary inflammation and extrapulmonary distribution.

Qiu J, Ma J, Dong Z, Ren Q, Shan Q, Liu J Nat Commun. 2024; 15(1):7396.

PMID: 39191805 PMC: 11349891. DOI: 10.1038/s41467-024-51686-y.


Thrombospondin-1 is an endogenous substrate of cereblon responsible for immunomodulatory drug-induced thromboembolism.

Hatakeyama K, Kikushige Y, Ishihara D, Yamamoto S, Kawano G, Tochigi T Blood Adv. 2024; 8(3):785-796.

PMID: 38163319 PMC: 10847748. DOI: 10.1182/bloodadvances.2023010080.


Current knowledge of thrombocytopenia in sepsis and COVID-19.

Cheng J, Zeng H, Chen H, Fan L, Xu C, Huang H Front Immunol. 2023; 14:1213510.

PMID: 37841241 PMC: 10568455. DOI: 10.3389/fimmu.2023.1213510.


Clever Experimental Designs: Shortcuts for Better iPSC Differentiation.

Yasui R, Sekine K, Taniguchi H Cells. 2021; 10(12).

PMID: 34944048 PMC: 8700474. DOI: 10.3390/cells10123540.


Process analysis of pluripotent stem cell differentiation to megakaryocytes to make platelets applying European GMP.

Lawrence M, Evans A, Moreau T, Bagnati M, Smart M, Hassan E NPJ Regen Med. 2021; 6(1):27.

PMID: 34040001 PMC: 8155004. DOI: 10.1038/s41536-021-00138-y.